Claus-Dieter Graf

Title: Claus-Dieter Graf: Innovator in Enantiomeric Processes

Introduction

Claus-Dieter Graf is a notable inventor based in Hattersheim, Germany. He has made significant contributions to the field of chemistry, particularly in the preparation of enantiomeric forms of 2,3-diaminopropionic acid derivatives. With a total of 2 patents, his work has implications in various applications within the pharmaceutical industry.

Latest Patents

Graf's latest patents focus on a process for the preparation of enantiomeric forms of 2,3-diaminopropionic acid derivatives. The disclosure details a method involving racemate resolution, where the separation of the racemate into its enantiomers occurs through the formation of diastereomeric salts. This process utilizes an enantiomerically pure auxiliary, followed by separation through fractional crystallization. This innovative approach enhances the efficiency and effectiveness of producing these important chemical compounds.

Career Highlights

Claus-Dieter Graf is currently associated with Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to contribute to advancements in pharmaceutical chemistry. His expertise in enantiomeric processes has positioned him as a valuable asset in the field.

Collaborations

Graf has collaborated with notable colleagues, including Joerg Rieke-Zapp. These collaborations have fostered an environment of innovation and shared knowledge, further enhancing the impact of their work in the industry.

Conclusion

Claus-Dieter Graf's contributions to the field of chemistry, particularly in the preparation of enantiomeric forms, demonstrate his commitment to innovation. His patents and work at Sanofi highlight the importance of his research in advancing pharmaceutical applications.